Gcnt2 Rat (-)-epigallocatechin 3-gallate multiple interactions ISO GCNT2 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GCNT2 mRNA CTD PMID:22079256 Gcnt2 Rat (S)-nicotine increases expression ISO Gcnt2 (Mus musculus) 6480464 Nicotine results in increased expression of GCNT2 mRNA CTD PMID:17997037 Gcnt2 Rat (S)-nicotine decreases expression ISO Gcnt2 (Mus musculus) 6480464 Nicotine results in decreased expression of GCNT2 mRNA CTD PMID:21955143 Gcnt2 Rat 1,2-dimethylhydrazine increases expression ISO Gcnt2 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of GCNT2 mRNA CTD PMID:22206623 Gcnt2 Rat 17beta-estradiol multiple interactions ISO GCNT2 (Homo sapiens) 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of GCNT2 mRNA CTD PMID:20823114 Gcnt2 Rat 17beta-estradiol decreases expression ISO Gcnt2 (Mus musculus) 6480464 Estradiol results in decreased expression of GCNT2 mRNA CTD PMID:39298647 Gcnt2 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Gcnt2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of GCNT2 mRNA CTD PMID:15800033 Gcnt2 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of GCNT2 mRNA CTD PMID:34747641 Gcnt2 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Gcnt2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of GCNT2 mRNA CTD PMID:21570461 Gcnt2 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of GCNT2 mRNA CTD PMID:21215274 and PMID:33387578 Gcnt2 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Gcnt2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to GCNT2 promoter] CTD PMID:19654925 Gcnt2 Rat 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO Gcnt2 (Mus musculus) 6480464 2 more ... CTD PMID:38648751 Gcnt2 Rat 2,4-dinitrobenzenesulfonic acid increases expression ISO Gcnt2 (Mus musculus) 6480464 2 and 4-dinitrobenzenesulfonic acid results in increased expression of GCNT2 mRNA CTD PMID:30116771 Gcnt2 Rat 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 Gcnt2 Rat 3,3',5,5'-tetrabromobisphenol A decreases expression EXP 6480464 tetrabromobisphenol A results in decreased expression of GCNT2 mRNA CTD PMID:28300664 Gcnt2 Rat 3,4-methylenedioxymethamphetamine increases expression ISO Gcnt2 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of GCNT2 mRNA CTD PMID:20188158 Gcnt2 Rat 4,4'-sulfonyldiphenol multiple interactions ISO Gcnt2 (Mus musculus) 6480464 [bisphenol S co-treated with Tretinoin] results in decreased expression of GCNT2 mRNA CTD PMID:30951980 Gcnt2 Rat 4,4'-sulfonyldiphenol affects methylation ISO Gcnt2 (Mus musculus) 6480464 bisphenol S affects the methylation of GCNT2 gene CTD PMID:31683443 Gcnt2 Rat 4,4'-sulfonyldiphenol increases methylation ISO Gcnt2 (Mus musculus) 6480464 bisphenol S results in increased methylation of GCNT2 exon CTD PMID:33297965 Gcnt2 Rat 4,4'-sulfonyldiphenol increases expression ISO Gcnt2 (Mus musculus) 6480464 bisphenol S results in increased expression of GCNT2 mRNA CTD PMID:30951980 Gcnt2 Rat 4-hydroxyphenyl retinamide increases expression ISO Gcnt2 (Mus musculus) 6480464 Fenretinide results in increased expression of GCNT2 mRNA CTD PMID:28973697 Gcnt2 Rat 5-azacytidine decreases expression ISO GCNT2 (Homo sapiens) 6480464 Azacitidine results in decreased expression of GCNT2 mRNA CTD PMID:20823114 Gcnt2 Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of GCNT2 mRNA CTD PMID:25825206 Gcnt2 Rat 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of GCNT2 mRNA CTD PMID:30047161 Gcnt2 Rat acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of GCNT2 mRNA CTD PMID:28959563 Gcnt2 Rat aflatoxin B1 increases expression ISO Gcnt2 (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of GCNT2 mRNA CTD PMID:19770486 Gcnt2 Rat all-trans-retinoic acid increases expression ISO Gcnt2 (Mus musculus) 6480464 Tretinoin results in increased expression of GCNT2 mRNA CTD PMID:16604517 Gcnt2 Rat all-trans-retinoic acid increases expression ISO GCNT2 (Homo sapiens) 6480464 Tretinoin results in increased expression of GCNT2 mRNA CTD PMID:33167477 Gcnt2 Rat all-trans-retinoic acid multiple interactions ISO Gcnt2 (Mus musculus) 6480464 [bisphenol A co-treated with Tretinoin] results in decreased expression of GCNT2 mRNA more ... CTD PMID:30951980 Gcnt2 Rat amitrole increases expression EXP 6480464 Amitrole results in increased expression of GCNT2 mRNA CTD PMID:30047161 Gcnt2 Rat amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of GCNT2 mRNA CTD PMID:30779732 Gcnt2 Rat arsane decreases expression ISO Gcnt2 (Mus musculus) 6480464 Arsenic results in decreased expression of GCNT2 mRNA CTD PMID:19654921 Gcnt2 Rat arsane multiple interactions ISO GCNT2 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GCNT2 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GCNT2 mRNA CTD PMID:39836092 Gcnt2 Rat arsenic atom decreases expression ISO Gcnt2 (Mus musculus) 6480464 Arsenic results in decreased expression of GCNT2 mRNA CTD PMID:19654921 Gcnt2 Rat arsenic atom multiple interactions ISO GCNT2 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GCNT2 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GCNT2 mRNA CTD PMID:39836092 Gcnt2 Rat arsenite(3-) increases methylation ISO GCNT2 (Homo sapiens) 6480464 arsenite results in increased methylation of GCNT2 promoter CTD PMID:23974009 Gcnt2 Rat benzo[a]pyrene decreases expression ISO Gcnt2 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of GCNT2 mRNA CTD PMID:19770486 Gcnt2 Rat benzo[a]pyrene decreases expression ISO GCNT2 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of GCNT2 mRNA CTD PMID:32234424 Gcnt2 Rat benzo[a]pyrene affects methylation ISO GCNT2 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of GCNT2 5' UTR and Benzo(a)pyrene affects the methylation of GCNT2 promoter CTD PMID:27901495 Gcnt2 Rat benzo[a]pyrene increases expression ISO GCNT2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of GCNT2 mRNA CTD PMID:20106945 and PMID:21632981 Gcnt2 Rat benzo[a]pyrene increases expression ISO Gcnt2 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of GCNT2 mRNA CTD PMID:22228805 Gcnt2 Rat benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of GCNT2 mRNA CTD PMID:21839799 Gcnt2 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of GCNT2 mRNA CTD PMID:25181051 more ... Gcnt2 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of GCNT2 mRNA CTD PMID:33296240 and PMID:34947998 Gcnt2 Rat bisphenol A increases expression ISO Gcnt2 (Mus musculus) 6480464 bisphenol A results in increased expression of GCNT2 mRNA CTD PMID:30951980 and PMID:32156529 Gcnt2 Rat bisphenol A multiple interactions ISO Gcnt2 (Mus musculus) 6480464 [bisphenol A co-treated with Tretinoin] results in decreased expression of GCNT2 mRNA CTD PMID:30951980 Gcnt2 Rat bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of GCNT2 gene CTD PMID:28505145 Gcnt2 Rat bisphenol F multiple interactions ISO Gcnt2 (Mus musculus) 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of GCNT2 mRNA CTD PMID:30951980 Gcnt2 Rat bisphenol F increases expression ISO Gcnt2 (Mus musculus) 6480464 bisphenol F results in increased expression of GCNT2 mRNA CTD PMID:30951980 Gcnt2 Rat bortezomib increases expression ISO GCNT2 (Homo sapiens) 6480464 Bortezomib results in increased expression of GCNT2 mRNA CTD PMID:20977926 Gcnt2 Rat bucladesine multiple interactions ISO GCNT2 (Homo sapiens) 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of GCNT2 mRNA CTD PMID:20823114 Gcnt2 Rat cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of GCNT2 mRNA CTD PMID:25993096 Gcnt2 Rat cadmium dichloride increases expression ISO GCNT2 (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of GCNT2 mRNA CTD PMID:38568856 Gcnt2 Rat carbon nanotube affects expression ISO Gcnt2 (Mus musculus) 6480464 Nanotubes and Carbon affects the expression of GCNT2 mRNA CTD PMID:25620056 Gcnt2 Rat carbon nanotube decreases expression ISO Gcnt2 (Mus musculus) 6480464 Nanotubes and Carbon analog results in decreased expression of GCNT2 mRNA CTD PMID:25554681 Gcnt2 Rat CGP 52608 multiple interactions ISO GCNT2 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to GCNT2 gene] CTD PMID:28238834 Gcnt2 Rat chlorpyrifos decreases expression ISO Gcnt2 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of GCNT2 mRNA CTD PMID:37019170 Gcnt2 Rat chromium(6+) decreases expression ISO GCNT2 (Homo sapiens) 6480464 chromium hexavalent ion results in decreased expression of GCNT2 mRNA CTD PMID:30690063 Gcnt2 Rat cisplatin affects response to substance ISO GCNT2 (Homo sapiens) 6480464 GCNT2 protein affects the susceptibility to Cisplatin CTD PMID:16217747 Gcnt2 Rat cocaine increases expression ISO Gcnt2 (Mus musculus) 6480464 Cocaine deficiency results in increased expression of GCNT2 mRNA CTD PMID:27126842 Gcnt2 Rat copper(II) sulfate increases expression ISO GCNT2 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of GCNT2 mRNA CTD PMID:19549813 Gcnt2 Rat cordycepin increases expression ISO Gcnt2 (Mus musculus) 6480464 cordycepin results in increased expression of GCNT2 mRNA CTD PMID:32042022 Gcnt2 Rat Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of GCNT2 mRNA CTD PMID:27523638 Gcnt2 Rat cyclosporin A increases expression ISO GCNT2 (Homo sapiens) 6480464 Cyclosporine results in increased expression of GCNT2 mRNA CTD PMID:25562108 Gcnt2 Rat cytarabine decreases expression ISO GCNT2 (Homo sapiens) 6480464 Cytarabine results in decreased expression of GCNT2 mRNA CTD PMID:21198554 Gcnt2 Rat decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of GCNT2 mRNA CTD PMID:23640034 Gcnt2 Rat dexamethasone increases expression ISO Gcnt2 (Mus musculus) 6480464 Dexamethasone results in increased expression of GCNT2 mRNA CTD PMID:22733784 Gcnt2 Rat diazinon increases methylation ISO GCNT2 (Homo sapiens) 6480464 Diazinon results in increased methylation of GCNT2 gene CTD PMID:22964155 Gcnt2 Rat diuron decreases expression EXP 6480464 Diuron results in decreased expression of GCNT2 mRNA CTD PMID:25152437 Gcnt2 Rat dorsomorphin multiple interactions ISO GCNT2 (Homo sapiens) 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GCNT2 mRNA CTD PMID:27188386 Gcnt2 Rat doxorubicin decreases expression ISO GCNT2 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of GCNT2 mRNA CTD PMID:29803840 Gcnt2 Rat emodin increases expression ISO Gcnt2 (Mus musculus) 6480464 Emodin results in increased expression of GCNT2 mRNA CTD PMID:15612046 Gcnt2 Rat endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of GCNT2 mRNA CTD PMID:29391264 Gcnt2 Rat epoxiconazole decreases expression ISO Gcnt2 (Mus musculus) 6480464 epoxiconazole results in decreased expression of GCNT2 mRNA CTD PMID:35436446 Gcnt2 Rat ethanol decreases expression ISO Gcnt2 (Mus musculus) 6480464 Ethanol results in decreased expression of GCNT2 mRNA CTD PMID:21955143 Gcnt2 Rat ethyl methanesulfonate decreases expression ISO GCNT2 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in decreased expression of GCNT2 mRNA CTD PMID:23649840 Gcnt2 Rat fentin chloride increases expression EXP 6480464 triphenyltin chloride results in increased expression of GCNT2 mRNA CTD PMID:37156404 Gcnt2 Rat formaldehyde decreases expression ISO GCNT2 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of GCNT2 mRNA CTD PMID:20655997 and PMID:23649840 Gcnt2 Rat furan increases expression ISO Gcnt2 (Mus musculus) 6480464 furan results in increased expression of GCNT2 mRNA CTD PMID:24183702 Gcnt2 Rat glafenine increases expression EXP 6480464 Glafenine results in increased expression of GCNT2 mRNA CTD PMID:24136188 Gcnt2 Rat glycidol decreases expression EXP 6480464 glycidol results in decreased expression of GCNT2 mRNA CTD PMID:24915197 Gcnt2 Rat inulin multiple interactions ISO Gcnt2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of GCNT2 mRNA CTD PMID:36331819 Gcnt2 Rat isoprenaline increases expression ISO Gcnt2 (Mus musculus) 6480464 Isoproterenol results in increased expression of GCNT2 mRNA CTD PMID:20003209 Gcnt2 Rat kainic acid increases expression ISO Gcnt2 (Mus musculus) 6480464 Kainic Acid results in increased expression of GCNT2 mRNA CTD PMID:17997037 Gcnt2 Rat manganese atom multiple interactions ISO GCNT2 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GCNT2 mRNA CTD PMID:39836092 Gcnt2 Rat manganese(0) multiple interactions ISO GCNT2 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GCNT2 mRNA CTD PMID:39836092 Gcnt2 Rat manganese(II) chloride multiple interactions ISO GCNT2 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GCNT2 mRNA CTD PMID:39836092 Gcnt2 Rat medroxyprogesterone acetate multiple interactions ISO GCNT2 (Homo sapiens) 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of GCNT2 mRNA CTD PMID:20823114 Gcnt2 Rat methimazole increases expression EXP 6480464 Methimazole results in increased expression of GCNT2 mRNA CTD PMID:30047161 Gcnt2 Rat methyl methanesulfonate decreases expression ISO GCNT2 (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of GCNT2 mRNA CTD PMID:23649840 Gcnt2 Rat morphine increases expression ISO Gcnt2 (Mus musculus) 6480464 Morphine results in increased expression of GCNT2 mRNA CTD PMID:21955143 Gcnt2 Rat morphine decreases expression ISO Gcnt2 (Mus musculus) 6480464 Morphine deficiency results in decreased expression of GCNT2 mRNA CTD PMID:27126842 Gcnt2 Rat N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of GCNT2 mRNA CTD PMID:19638242 Gcnt2 Rat nickel sulfate increases expression ISO GCNT2 (Homo sapiens) 6480464 nickel sulfate results in increased expression of GCNT2 mRNA CTD PMID:22714537 Gcnt2 Rat nicotine increases expression ISO Gcnt2 (Mus musculus) 6480464 Nicotine results in increased expression of GCNT2 mRNA CTD PMID:17997037 Gcnt2 Rat nicotine decreases expression ISO Gcnt2 (Mus musculus) 6480464 Nicotine results in decreased expression of GCNT2 mRNA CTD PMID:21955143 Gcnt2 Rat nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of GCNT2 mRNA CTD PMID:26720608 Gcnt2 Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of GCNT2 mRNA CTD PMID:25729387 Gcnt2 Rat ozone increases expression ISO Gcnt2 (Mus musculus) 6480464 Ozone results in increased expression of GCNT2 mRNA CTD PMID:19555225 Gcnt2 Rat paracetamol decreases expression ISO GCNT2 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of GCNT2 mRNA CTD PMID:21420995 and PMID:29067470 Gcnt2 Rat paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of GCNT2 mRNA CTD PMID:33387578 Gcnt2 Rat perfluorooctane-1-sulfonic acid affects expression ISO Gcnt2 (Mus musculus) 6480464 perfluorooctane sulfonic acid affects the expression of GCNT2 mRNA CTD PMID:19429403 Gcnt2 Rat perfluorooctane-1-sulfonic acid multiple interactions ISO Gcnt2 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of GCNT2 mRNA CTD PMID:36331819 Gcnt2 Rat perfluorooctanoic acid affects expression ISO Gcnt2 (Mus musculus) 6480464 perfluorooctanoic acid affects the expression of GCNT2 mRNA CTD PMID:19429403 Gcnt2 Rat phenobarbital affects expression ISO Gcnt2 (Mus musculus) 6480464 Phenobarbital affects the expression of GCNT2 mRNA CTD PMID:23091169 Gcnt2 Rat pirinixic acid increases expression ISO Gcnt2 (Mus musculus) 6480464 pirinixic acid results in increased expression of GCNT2 mRNA CTD PMID:17426115 and PMID:18445702 Gcnt2 Rat pirinixic acid decreases expression ISO Gcnt2 (Mus musculus) 6480464 pirinixic acid results in decreased expression of GCNT2 mRNA CTD PMID:23811191 Gcnt2 Rat potassium chromate multiple interactions ISO GCNT2 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GCNT2 mRNA CTD PMID:22079256 Gcnt2 Rat potassium chromate decreases expression ISO GCNT2 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of GCNT2 mRNA CTD PMID:22079256 and PMID:22714537 Gcnt2 Rat pravastatin increases expression ISO Gcnt2 (Mus musculus) 6480464 Pravastatin results in increased expression of GCNT2 mRNA CTD PMID:27225895 Gcnt2 Rat pravastatin decreases expression EXP 6480464 Pravastatin results in decreased expression of GCNT2 mRNA CTD PMID:27225895 Gcnt2 Rat propiconazole increases expression EXP 6480464 propiconazole results in increased expression of GCNT2 mRNA CTD PMID:30047161 Gcnt2 Rat quercetin decreases expression ISO GCNT2 (Homo sapiens) 6480464 Quercetin results in decreased expression of GCNT2 mRNA CTD PMID:21632981 Gcnt2 Rat quinolin-8-ol increases expression ISO Gcnt2 (Mus musculus) 6480464 Oxyquinoline results in increased expression of GCNT2 mRNA CTD PMID:15612046 Gcnt2 Rat resveratrol multiple interactions ISO GCNT2 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of GCNT2 mRNA CTD PMID:23557933 Gcnt2 Rat SB 431542 multiple interactions ISO GCNT2 (Homo sapiens) 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GCNT2 mRNA CTD PMID:27188386 Gcnt2 Rat silver atom increases expression ISO GCNT2 (Homo sapiens) 6480464 Silver results in increased expression of GCNT2 mRNA CTD PMID:26014281 Gcnt2 Rat silver(0) increases expression ISO GCNT2 (Homo sapiens) 6480464 Silver results in increased expression of GCNT2 mRNA CTD PMID:26014281 Gcnt2 Rat sodium arsenite increases expression ISO Gcnt2 (Mus musculus) 6480464 sodium arsenite results in increased expression of GCNT2 mRNA CTD PMID:18812580 Gcnt2 Rat sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of GCNT2 mRNA CTD PMID:35314868 Gcnt2 Rat sodium arsenite multiple interactions ISO GCNT2 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in increased expression of GCNT2 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of GCNT2 mRNA CTD PMID:39836092 Gcnt2 Rat sodium arsenite increases expression ISO GCNT2 (Homo sapiens) 6480464 sodium arsenite results in increased expression of GCNT2 mRNA CTD PMID:38568856 Gcnt2 Rat Soman increases expression EXP 6480464 Soman results in increased expression of GCNT2 mRNA CTD PMID:19281266 Gcnt2 Rat streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of GCNT2 mRNA CTD PMID:25905778 Gcnt2 Rat sunitinib decreases expression ISO GCNT2 (Homo sapiens) 6480464 Sunitinib results in decreased expression of GCNT2 mRNA CTD PMID:31533062 Gcnt2 Rat temozolomide increases expression ISO GCNT2 (Homo sapiens) 6480464 Temozolomide results in increased expression of GCNT2 mRNA CTD PMID:31758290 Gcnt2 Rat testosterone increases expression ISO Gcnt2 (Mus musculus) 6480464 Testosterone deficiency results in increased expression of GCNT2 mRNA CTD PMID:33848595 Gcnt2 Rat tetrachloromethane affects expression ISO Gcnt2 (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of GCNT2 mRNA CTD PMID:17484886 Gcnt2 Rat tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of GCNT2 mRNA CTD PMID:31150632 Gcnt2 Rat thalidomide decreases expression ISO Gcnt2 (Mus musculus) 6480464 Thalidomide results in decreased expression of GCNT2 mRNA CTD PMID:26217789 Gcnt2 Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of GCNT2 mRNA CTD PMID:34492290 Gcnt2 Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of GCNT2 mRNA CTD PMID:25729387 Gcnt2 Rat topotecan increases expression EXP 6480464 Topotecan results in increased expression of GCNT2 mRNA CTD PMID:25729387 Gcnt2 Rat triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of GCNT2 mRNA CTD PMID:30589522 Gcnt2 Rat valproic acid affects expression ISO GCNT2 (Homo sapiens) 6480464 Valproic Acid affects the expression of GCNT2 mRNA CTD PMID:25979313 Gcnt2 Rat vanadyl sulfate increases expression ISO GCNT2 (Homo sapiens) 6480464 vanadyl sulfate results in increased expression of GCNT2 mRNA CTD PMID:16330358 Gcnt2 Rat vorinostat multiple interactions ISO GCNT2 (Homo sapiens) 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GCNT2 mRNA CTD PMID:27188386 Gcnt2 Rat zaragozic acid A affects expression ISO Gcnt2 (Mus musculus) 6480464 squalestatin 1 affects the expression of GCNT2 mRNA CTD PMID:27225895 Gcnt2 Rat zaragozic acid A decreases expression EXP 6480464 squalestatin 1 results in decreased expression of GCNT2 mRNA CTD PMID:27225895 Gcnt2 Rat zinc atom multiple interactions ISO GCNT2 (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of GCNT2 mRNA CTD PMID:18593933 Gcnt2 Rat zinc(0) multiple interactions ISO GCNT2 (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of GCNT2 mRNA CTD PMID:18593933